Nutritional, functional, and emotional characteristics related to fatigue in patients during and after biochemotherapy

Oncology Nursing Forum

Volumn 32, Issue 3, 2005, Pages 661-667

  Porock, Davina ^a,b   Beshears, Brenda ^b   Hinton, Pam ^b,c   Anderson, Clay ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF MISSOURI   (United States)

^c Department of Nutrition Science ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FATIGUE; FEMALE; HUMAN; MALE; MELANOMA; MIDDLE AGED; MOTOR ACTIVITY; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOTOR ACTIVITY; NUTRITIONAL STATUS; QUESTIONNAIRES;

EID: 32044470223     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/05.ONF.661-667     Document Type: Article

References (36)

1. Balducci, L., & Extermann, M. (2000). Management of the frail person with advanced cancer. Critical Reviews in Oncology/Hematology, 33, 143-148.
2. Beach, P., Siebeneck, B., Buderer, N.F., & Ferner, T. (2001). Relationship between fatigue and nutritional status in patients receiving radiation therapy to treat lung cancer. Oncology Nursing Forum, 28, 1027-1031.
3. Bingham, S.A., Gill, C., Welch, A., Day, K., Cassidy, A., Khaw, K.T., et al. (1994). Comparison of dietary assessment methods in nutritional epidemiology: Weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. British Journal of Nutrition, 72, 619-643.
4. Courneya, K.S., & Friedenreich, C.M. (1997). Relationship between exercise during treatment and current quality of life among survivors of breast cancer. Journal of Psychosocial Oncology, 15(3/4), 35-57.
5. Courneya, K.S., & Friedenreich, C.M. (1999). Physical exercise and quality of life following cancer diagnosis: A literature review. Annals of Behavioral Medicine, 21, 171-179.
6. Cuaron, L., &, Thompson, J. (1995). The interferons. In P.T. Rieger (Ed.), Biotherapy: A comprehensive overview (pp. 125-194). Sudbury, MA: Jones and Bartlett.
7. Dean, G.E., Spears, L., Ferrell, B.R., Quan, W.D., Groshon, S., & Mitchell, M.S. (1995). Fatigue in patients with cancer receiving interferon alpha. Cancer Practice, 3, 164-172.
8. Donnelly, S. (1998). Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma. Oncology Nursing Forum, 25, 921-927.
9. Figlin, R.A., Belldegrun, A., Moldawer, N., Zeffren, J., & deKernion, J. (1992). Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A: An active outpatient regimen in metastatic renal cell carcinoma. Journal of Clinical Oncology, 10, 414-421.
10. Fleming, G.F., Schilsky, R.L., Schumm, L.P., Meyerson. A., Hong, A.M., Vogelzang, N.J., et al. (2003). Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction. Annals of Oncology, 14, 1142-1147.
11. Fu, M.R., Anderson, C.M., McDaniel, R., & Armer, J. (2002). Patients' perceptions of fatigue in response to biochemotherapy for metastatic melanoma: A preliminary study. Oncology Nursing Forum, 29, 961-966.
12. Godin, G., & Bouillon, J. (1986). Assessment of leisure time exercise behavior by self-report: A concurrent validity study. Canadian Journal of Public Health, 77, 359-362.
13. Godin, G., & Shephard, R.J. (1985). A simple method to assess exercise behavior in the community. Canadian Journal of Applied Sport Sciences, 10, 141-146.
14. Graham, K.Y., & Longman, A.J. (1987). Quality of life and persons with melanoma: Preliminary model testing. Cancer Nursing, 10, 338-346.
15. Grieco, A., & Long, C.L. (1984). Investigation of the Karnofsky Performance Status as a measure of quality of life. Health Psychology 3, 129-142.
16. Hirsh, M., Lipton, A., Harvey, H., Givant, E., Hopper, K., Jones, G., et al. (1990). Phase I study of interleukin-2 and interferon alpha-2a as outpatient therapy for patients with advanced malignancy. Journal of Clinical Oncology, 8, 1657-1663.
17. Kaasa, T., Loomis, J., Gillis, K., Bruera, E., & Hanson, J. (1997). The Edmonton Functional Assessment Tool: Preliminary development and evaluation for use in palliative care. Journal of Pain and Symptom Management, 13, 10-19.
18. Karnofsky, D.A., Abelmann, W.H., Craver, L.F., & Burchenal, J.H. (1948). The use of nitrogen mustard in the palliative treatment of cancer. Cancer, 1, 634-656.
19. Kirkwood, J.M., Bender, C., Agarwala, S., Tarhini, A., Shipe-Spotloe, J., Smelko, B., et al. (2002). Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. Journal of Clinical Oncology, 20, 3703-3718.
20. Mahich, E., & Fefer, A. (Eds.). (1983). Biological response modifiers: Subcommittee report [Monograph 63]. Washington, DC: National Cancer Institute.
21. Orr, ST., & Aisner, J. (1986). Performance status assessment among oncology patients: A review. Cancer Treatment Reports, 70, 1423-1429.
22. Parkinson, D.R. (1989). The role of interleukin-2 in the biotherapy of cancer. Oncology Nursing Forum, 16(Suppl. 6), 16-20.
23. Piper, B.F., Lindsey, A.M., & Dodd, M.J. (1987). Fatigue mechanisms in cancer patients: Developing nursing theory. Oncology Nursing Forum, 14(6), 17-23.
24. Porock, D., & Juenger, J. (2004). Just go with the flow: A qualitative study of fatigue in biotherapy. European Journal of Cancer Care, 13, 356-361.
25. Quesada, J.R., Talpaz, M., Rios, A., Kuzrock, R., & Gutterman, J.U. (1986). Clinical toxicity of interferons in cancer patients: A review. Journal of Clinical Oncology, 4, 234-243.
26. Rieger, P.H. (1997). Biotherapy. In S.E. Otto (Ed.), Oncology nursing (3rd ed., pp. 573-613). St. Louis, MO: Mosby.
27. Rhodes, V., McDaniel, R.W., Homan, S.S., Johnson, M., & Madsen, R. (2000). An instrument to measure symptom experience. Cancer Nursing, 23, 49-54.
28. Schwartz, A.L. (1998). Patterns of exercise and fatigue in physically active cancer survivors. Oncology Nursing Forum, 25, 485-491.
29. Schwartz, A.L., Thompson, J.A., & Masood, N. (2002). Interferon-induced fatigue in patients with melanoma: A pilot study of exercise and methylphenidate [Online exclusive]. Oncology Nursing Forum, 29, E85-E90. Retrieved February 28, 2005, from http://www.ons.org/publications/ journals/ONF/Volume29/Issue7/pdf/85.pdf
30. Skalla, K.A., & Reiger, P.T. (1995). Fatigue. In P.T. Reiger (Ed.), Biotherapy: A comprehensive overview (pp. 221-242). Sudbury, MA: Jones and Bartlett.
31. Smets, E.M., Garssen, B., Schuster-Uitterhoeve, A.L., & de Haes, J.C. (1993). Fatigue in cancer patients. British Journal of Cancer, 68, 220-224.
32. Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., & Amadori, S. (2003). Cancer-related fatigue: Evolving concepts in evaluation and treatment. Cancer, 98, 1786-1801.
33. Wheeler, V.S. (1997). Biotherapy. In S.L. Groenwald, M. Frogge, M. Goodman, & C.H. Yarbro (Eds.), Cancer nursing: Principles and practice (4th ed., pp. 426-458). Sudbury, MA: Jones and Bartlett.
34. Whitney, E.N., Cataldo, C.B., & Rolfes, S.R. (2002). Understanding normal and clinical nutrition (Computer software: Diet Analysis Plus 6.0) (6th ed.). Belmont, CA: Wadsworth.
35. Winningham, M.L. (1992). The role of exercise in cancer therapy. In R.R. Watson & M. Eisinger (Eds.), Exercise and disease (pp. 64-70). Boca Raton, FL: CRC Press.
36. Zigmond, A.S., & Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370.